News

Immunizations “are not all good or bad,” says the chair of the overhauled panel.
The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...
Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...
Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.
A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...
The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...
Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...
Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used objectively to set vaccine policy.